SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019687-04-002350
Filing Date
2004-10-28
Accepted
2004-10-28 17:40:01
Documents
1
Period of Report
2004-10-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2842
  Complete submission text file 0001019687-04-002350.txt   4754
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 10875 FEMAH LANE SAN DIEGO CA 92131
POHL DAVID (Reporting) CIK: 0001233396 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17085 | Film No.: 041103712